Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bearish
Celltrion Healthcare
Watchlist
Celltrion Healthcare IPO Part 6 - IPO Bookbuilding Results
Equity Capital Markets
298 Views
17 Jul 2017 10:51
Celltrion Healthcare (091990 KS) IPO price was set at ₩41,000, which is the highest level of the indicative price band (₩32,500 - ₩41,000). The...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 2-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Asia ECM
South Korea
Equity Bottom-Up
Event-Driven
Asia Event-Driven
Sell / Short Ideas
Japan
Philippines
Financials
Trending Insights
More »
NTT DC REIT IPO: The Investment Case
HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added
Ohayo Japan | Jobs Data Lifts Wall Street to Record Highs
Anjoy Foods Group A/H Trading - Cheap Price but Sluggish Demand
[Japan M&A] YAGEO Extends Shibaura TOB Limbo at FSA/METI/BOJ Request on FEFTA
Top Unpaywalled Insights
More »
Oversupply Meets Tepid Demand Weighing Down on Soybean Meal
[IO Technicals 2025/26] Bearish Momentum Intensifies
"The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Recap on Celltrion Healthcare IPO Day - Retail Investors Turned Positive, Why?
30 Jul 2017
Biogen Likes Biosimilars
25 Jul 2017
JNJ's REMICADE Holds: PFE's Results To Confirm
18 Jul 2017
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
17 Jul 2017
Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate
12 Jul 2017
Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind
03 Jul 2017
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x